rheumatologyadvisor7h
FDA to Review Sublingual Cyclobenzaprine for Fibromyalgia Management
The FDA has accepted the NDA for TNX-102 SL (cyclobenzaprine HCL sublingual tablets) for the management of fibromyalgia.
Medscape3d
Current and Future Treatment Modalities for Clostridium difficile-Associated Disease
[43] Fewer treatment failures occurred with vancomycin use, but the difference was not ... in which 18 patients received a single 200-300-mg/kg dose of IVIG in combination with i.v. metronidazole ...
Medscape2d
New Insights into the Prevention of Staphylococcal Infections and Toxic Shock Syndrome
Antibiotics that inhibit protein synthesis ... of bacterial ribosome inhibiting RNA-dependent protein synthesis. Clindamycin (a lincosamide) at subgrowth inhibitory concentrations was able to ...